ELABS — Elliptic Laboratories ASA Balance Sheet
0.000.00%
- NOK750.61m
- NOK710.43m
- NOK131.91m
- 59
- 20
- 14
- 17
Annual balance sheet for Elliptic Laboratories ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | NAS | NAS | NAS | NAS | NAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 98.6 | 217 | 176 | 113 | 74.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 18.2 | 46.7 | 47.3 | 67 | 118 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 122 | 265 | 226 | 186 | 195 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.02 | 2.79 | 2.26 | 19.9 | 16.7 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 219 | 371 | 349 | 348 | 361 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.6 | 18.1 | 17.2 | 24.9 | 25 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.6 | 28.6 | 23.7 | 42.8 | 35.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Other Equity | |||||
| Total Equity | 188 | 343 | 326 | 305 | 325 |
| Total Liabilities & Shareholders' Equity | 219 | 371 | 349 | 348 | 361 |
| Total Common Shares Outstanding |